Sector Pulse — March 20, 2026

Technology

Theme: AI infrastructure and enterprise AI remained the dominant narrative, but the tone split between companies capturing spend with real product/CapEx momentum and software names still being repriced by macro rates, geopolitics, and valuation stress. Hardware, networking, and infrastructure enablers had the clearest positive read-throughs, while selective software names faced execution, competition, or legal credibility questions.

Movers:

NVDA(Nvidia): Continued to anchor the AI buildout narrative, with ecosystem demand spanning autonomous systems, edge AI, and next-gen chips. This matters because Nvidia remains the demand signal for the entire AI stack, from semicap to networking to cooling.
AMZN(Amazon): The company’s $100 billion AI Manufacturing Fund and effort to secure 1 million Nvidia GPUs by 2027 reinforced that hyperscalers are still in an all-out infrastructure arms race. This matters because AWS is moving from cloud operator to AI infrastructure sovereign, supporting broad capex beneficiaries.
MSFT(Microsoft): Azure growth and AI product penetration remained strong, but the market also focused on competitive risk in PCs and the broader rate-sensitive tech selloff. It matters because Microsoft is still one of the cleanest enterprise AI monetization stories, even as macro volatility compresses multiples.
GOOGL(Alphabet): Google’s AI product push, cloud momentum, and infrastructure spending reinforced its leadership stance, with moves like Stitch also putting pressure on adjacent software categories. This matters because Alphabet is proving AI is monetizable across cloud, search, workspace, and design workflows.
ORCL(Oracle): Its $553 billion backlog became the centerpiece of the bull case, showing Oracle has pre-sold a massive chunk of future AI/cloud demand. It matters because Oracle has become a serious AI infrastructure landlord, though financing and legal scrutiny remain a live debate.
DELL(Dell): Benefited from AI server demand and from the fallout at a key rival after legal trouble at Super Micro. This matters because Dell is gaining share as customers favor compliant, enterprise-grade AI infrastructure vendors.
SMCI(Super Micro Computer): The federal indictment tied to alleged AI server smuggling to China was today’s biggest negative shock in the group. It matters because this is now an existential compliance event, with implications far beyond one company for AI hardware governance and export controls.
AVGO(Broadcom): Continued to stand out as a foundational AI winner via custom ASICs and networking, with a credible path to outsized AI revenue. This matters because Broadcom is monetizing AI through both compute and connectivity, giving it one of the broadest moats in the group.
ANET(Arista Networks): Benefited from the view that network capacity is now as essential as compute in AI clusters. It matters because AI data center scaling is pulling through high-end networking spend alongside GPU demand.
CDNS(Cadence Design Systems): The Nvidia-linked push into AI-native design workflows and system engineering marked a meaningful strategic inflection. It matters because EDA is becoming an AI bottleneck beneficiary, not just a passive tools category.
AMD(Advanced Micro Devices): Long-term AI infrastructure momentum stayed intact, but shares were vulnerable to sector-wide fear around export controls and AI hardware scrutiny. It matters because AMD remains a core second-source AI beneficiary, but sentiment is fragile.
ADBE(Adobe): Faced renewed pressure from AI-native competitors and leadership uncertainty, deepening the market’s concern that its moat is being challenged. It matters because Adobe has become a key test case for whether incumbent software can defend against generative AI disruption.
FIG(Figma): Margin deterioration and pressure from Google’s AI-first design tooling sharpened the market’s concerns over its standalone durability. It matters because design software is becoming a front-line battlefield for AI commoditization.
GDDY(GoDaddy): Weak results and a securities fraud investigation created a credibility problem. It matters because the issue is no longer just growth slowdown, but governance and disclosure trust.
SNOW(Snowflake): AI product momentum was overshadowed by securities litigation alleging misleading disclosures on revenue dynamics. It matters because investors are now scrutinizing not just growth, but the quality and transparency of that growth.
CRM(Salesforce): Agentforce and data-layer integration kept the AI transformation narrative alive, even as investors debate whether growth is slowing too much to support the multiple. It matters because Salesforce remains one of the biggest tests of AI monetization in enterprise software.
OKTA(Okta): Its agentic identity push gained traction and showed real booking uplift. It matters because identity is becoming a critical control layer for enterprise AI adoption.
CRWD(CrowdStrike): Strategic positioning in AI-era cloud security remains strong, but the stock was hit by a macro-driven de-risking move. It matters because high-multiple cybersecurity remains hostage to rates and sentiment despite strong fundamentals.

Watch:

SMCI(Super Micro Computer) fallout and any resulting tighter export-control enforcement; this is the most immediate risk transmission channel into semis and AI infrastructure.
Whether hyperscaler AI capex remains unbroken through the next earnings cycle, especially at AMZN(Amazon), MSFT(Microsoft), GOOGL(Alphabet), and the downstream beneficiaries NVDA(Nvidia), AVGO(Broadcom), ANET(Arista Networks), VRT(Vertiv), and DELL(Dell).

Financials

Theme: Financials were defined by a split between capital-light compounders and alternative managers with strategic momentum versus firms facing governance, litigation, private-credit liquidity, or regulatory risk. At the same time, the sector remained tightly tethered to rate expectations and regulatory change, especially around capital requirements and crypto policy.

Movers:

BAC(Bank of America): The combination of potential capital-rule easing and its push into digital finance/stablecoins kept the strategic narrative alive despite weak stock performance. It matters because regulatory relief could materially free up capital for lending, buybacks, and product investment.
JPM(JPMorgan Chase): Remained central to the macro debate through its hawkish rate views and role in major financing activity, while also navigating a tougher environment for rates-sensitive bank multiples. It matters because JPM is both a market signal and a balance-sheet bellwether.
WFC(Wells Fargo): The removal of the asset cap remains the core strategic unlock for growth and efficiency. It matters because Wells now has a real regulatory path to re-rate if execution catches up.
PNC(PNC Financial Services): A potential reduction in capital requirements for mid-sized banks offers a targeted tailwind. It matters because regional banks with mortgage and lending exposure could regain offensive capacity.
HBAN(Huntington Bancshares): Its aggressive buyback plan tied to M&A integration success highlighted the upside/downside asymmetry in regional bank execution. It matters because capital return is being used as a signal of confidence, but also raises the cost of execution failure.
BNS(Scotiabank): Its move to increase its stake in KEY(KeyCorp) signaled a strategic U.S. banking push. It matters because cross-border consolidation ambitions are returning despite a fragile macro backdrop.
KEY(KeyCorp): Became a strategic asset in the U.S. regional bank landscape through Scotiabank’s increased interest. It matters because a larger shareholder with strategic intent can reshape governance and valuation.
APO(Apollo Global Management): The securities class action and renewed Epstein-linked scrutiny around current leadership represented one of the most severe reputational shocks in the group. It matters because this is no longer legacy overhang—it directly challenges management credibility and franchise trust.
BX(Blackstone): Strong earnings expectations were overshadowed by private credit and BDC liquidity fragility. It matters because redemption pressure and gated vehicles have become the central risk to the alternatives model.
ARES(Ares Management): A large dividend hike showed confidence, but also raised concerns about payout sustainability versus earnings. It matters because investors are starting to differentiate between durable fee streams and over-extended capital return promises.
ARCC(Ares Capital): Its role in a large, high-spread unitranche deal highlighted a repricing in private credit back toward lenders. It matters because higher spreads can help returns, but also confirm tighter credit conditions.
COIN(Coinbase): Remained a key expression of crypto market infrastructure risk, with cybersecurity and earnings sensitivity front and center. It matters because crypto trust and custody remain existential issues after major ecosystem hacks.
HOOD(Robinhood): The Q4 miss refocused the market on the gap between engagement growth and earnings durability. It matters because high retail activity is no longer enough without evidence of scalable profitability.
IBKR(Interactive Brokers): Continued to separate itself with strong account and trading growth plus a potential trust-bank charter catalyst. It matters because IBKR is evolving from broker to more complete financial platform.
PYPL(PayPal): The securities class action around disclosure and strategy execution deepened the credibility discount. It matters because PayPal’s problem is now trust in management narrative as much as growth.
AXP(American Express): Buffett’s enduring support kept attention on quality, affluent consumer exposure, and long-duration compounding. It matters because AXP remains one of the cleaner consumer-financial franchises if spending holds.
CB(Chubb): Its role in the U.S. maritime reinsurance plan tied the insurer directly to geopolitical shipping risk. It matters because Chubb has become a tradable proxy for conflict-related marine insurance exposure.
BCS(Barclays) and SAN(Banco Santander): Their ties to the MFS fraud scandal exposed weak points in shadow-bank diligence. It matters because private-credit and non-bank lender exposure is becoming a regulatory and confidence risk for traditional banks too.

Watch:

Private credit liquidity: redemption pressure, BDC gating, and wider spreads are becoming the sector’s most important stress signal.
Fed and capital-rule developments for money-center and regional banks, with WFC(Wells Fargo), BAC(Bank of America), PNC(PNC Financial Services), and TFC(Truist Financial) among the clearest beneficiaries if relief is finalized.

Healthcare

Theme: Healthcare flow was dominated by pipeline catalysts, M&A, and therapeutic category disruption, especially in oncology, immunology, obesity, and neurodegeneration. The strongest stories involved companies using approvals, acquisitions, or late-stage data to redefine growth, while laggards were being punished for competitive erosion, weak guidance, or fading investor conviction.

Movers:

ABT(Abbott Laboratories): Its acquisition of EXAS(Exact Sciences) was one of the day’s largest strategic healthcare moves, repositioning Abbott deeper into cancer diagnostics. It matters because Abbott is buying into a structurally attractive early-detection and precision-oncology market, even at the cost of near-term dilution.
BMY(Bristol-Myers Squibb): FDA wins for Opdivo and Sotyktu reinforced a diversification narrative beyond legacy fears. It matters because these approvals strengthen BMY’s case as an undervalued biopharma with real commercial catalysts.
JNJ(Johnson & Johnson): The approval of icotrokinra reshaped the competitive map in inflammatory disease. It matters because JNJ is leveraging oral convenience to attack entrenched injectable franchises.
ABBV(AbbVie): Strong execution in core immunology was overshadowed by the competitive threat from JNJ’s oral IL-23 entrant. It matters because AbbVie’s most valuable franchises are now facing a structural convenience challenge, not just routine competition.
BIIB(Biogen): Real-world LEQEMBI persistence data and the coming May PDUFA on the subcutaneous formulation sharpened the Alzheimer’s upside case. It matters because home-use administration could materially expand the addressable market and improve franchise durability.
LLY(Eli Lilly): Retatrutide’s obesity data kept Lilly at the center of the metabolic therapy arms race. It matters because retatrutide may reset efficacy expectations in obesity and diabetes, with major implications for the whole category.
NVO(Novo Nordisk): Wegovy innovation remained strong, but patent risk, regulatory scrutiny, and competitive pressure weighed on sentiment. It matters because the market is now shifting from rewarding category leadership to stress-testing durability and pricing power.
VRTX(Vertex Pharmaceuticals): Positive RAINIER data for povetacicept strengthened the non-CF diversification case. It matters because Vertex needs non-CF revenue pillars to justify its next phase of growth.
NVS(Novartis): The $3 billion Synnovation acquisition showed a high-conviction oncology pipeline bet. It matters because Novartis is paying early for strategic precision-oncology optionality rather than waiting for de-risking.
GEHC(GE HealthCare): The Intelerad acquisition marked a major move toward recurring, cloud-based imaging software. It matters because GEHC is shifting from hardware vendor toward software-enabled diagnostics platform.
CAH(Cardinal Health): Its expanding role in nuclear medicine distribution highlighted a less-appreciated growth vector. It matters because Cardinal is becoming healthcare infrastructure for theranostics, not just a distributor.
BSX(Boston Scientific): Innovation remains intact, but tariff scrutiny and a weaker market narrative around medtech raised caution. It matters because policy uncertainty can now move medtech valuations even when product momentum is solid.
AMGN(Amgen): Otezla’s competitive moat is under pressure from newer oral therapies. It matters because Amgen is losing exclusivity of convenience in an important autoimmune category.
CNC(Centene): The scale of the loss and policy sensitivity kept the stock in crisis territory. It matters because managed care names tied to government reimbursement remain highly exposed to political and medical cost volatility.
UNH(UnitedHealth Group) and CVS(CVS Health): Both remain highly exposed to Medicare Advantage reimbursement pressure into 2027. It matters because the MA model itself is under active repricing by regulators and the market.
DHR(Danaher): The upcoming earnings call became more important as investors look for signs of stabilization in life sciences demand. It matters because Danaher is still a key read-through on biotech spending and diagnostics confidence.
MRNA(Moderna): VX-522 readout timing kept focus on whether Moderna can broaden mRNA beyond vaccines. It matters because this is one of the clearest tests of platform credibility outside infectious disease.

Watch:

BIIB(Biogen) on the May 24 PDUFA for subcutaneous lecanemab, a potentially franchise-expanding delivery catalyst.
MA reimbursement and policy pressure across UNH(UnitedHealth Group), CVS(CVS Health), and HUM(Humana), which remains the biggest structural debate in managed care.

Energy

Theme: Energy was driven almost entirely by geopolitical supply shock, with the market rapidly repricing companies according to their exposure to higher oil/LNG prices versus direct operational damage in the Middle East. The result was a sharp divide between names benefiting from disrupted global supply and those facing project, production, or infrastructure risk.

Movers:

CVX(Chevron): One of the clearest beneficiaries of the oil spike, helped by analyst upgrades and Berkshire’s large position. It matters because Chevron is being treated as a fortress balance-sheet way to monetize sustained geopolitical tightness.
XOM(Exxon Mobil): Higher oil prices are supportive, but direct exposure to damaged Qatari LNG infrastructure introduced a more complicated risk/reward profile. It matters because Exxon is both a beneficiary of price and a victim of the conflict’s operational fallout.
OXY(Occidental Petroleum): Debt reduction and equity-holder support remained positives, but halted production and export disruption raised a major earnings risk. It matters because Occidental’s leverage to crude is strong, but its direct operating exposure to conflict has become material.
LNG(Cheniere Energy): The damage to Qatar’s LNG export system sharply strengthened the case for U.S. LNG exporters. It matters because Cheniere is now a strategic substitute supplier, not just a cyclical exporter.
VG(Venture Global): Rallied with the view that Qatar’s outage structurally improves the setup for U.S. LNG developers. It matters because global gas buyers may need more U.S. molecules for longer.
ET(Energy Transfer): Its relevance expanded beyond pipelines into AI/data-center energy demand through new partnerships. It matters because Energy Transfer is trying to attach itself to the next wave of power-intensive infrastructure demand.
SLB(SLB): The company’s digital recurring revenue and capital return strategy reinforced its evolution beyond a traditional services name. It matters because SLB is becoming more software and less purely cyclical oilfield beta.
HAL(Halliburton): The automated well-placement milestone in Guyana was a major technology marker. It matters because Halliburton is trying to re-rate as a digital oilfield innovator, not just a service contractor.
BKR(Baker Hughes): The market is now waiting on earnings and guidance as a read-through on energy tech demand. It matters because Baker Hughes remains a bellwether for the capex/efficiency side of the energy cycle.
BP(BP): The refinery divestiture advanced the cost-rationalization and portfolio-reset story. It matters because BP is trying to prove it can shrink weaker legacy assets while preserving strategic optionality.
SHEL(Shell): A raised target price was offset by direct geopolitical exposure through disrupted Gulf LNG infrastructure. It matters because Shell’s integrated model offers upside to higher prices, but also leaves it more exposed to real asset damage.
TTE(TotalEnergies): The market focused on the company’s strategic repositioning via renewables and circularity, even as the integrated oil trade remained supported by higher prices. It matters because Total is one of the clearest examples of a major trying to blend hydrocarbon cash flow with energy-transition capex.
E(Eni): Continued to stand out as one of the more coherent transition stories among European majors. It matters because the market is rewarding firms that can fund energy transition without surrendering hydrocarbon cash flow.
EQNR(Equinor): Benefited from both strong gas leverage and exploration progress, especially with Europe needing secure supply. It matters because Equinor is now a direct proxy for European energy security plus offshore optionality.
APD(Air Products and Chemicals): Higher helium prices help, but Middle East instability is now a direct risk to the NEOM hydrogen project. It matters because Air Products is simultaneously a beneficiary of disrupted industrial gas supply and a hostage to regional project risk.
FANG(Diamondback Energy), MPC(Marathon Petroleum), PSX(Phillips 66), SUN(Sunoco), and SU(Suncor): All benefited from stronger commodity and refined-product conditions, though refining names face the usual risk that the market over-extrapolates near-term price strength.

Watch:

Qatar LNG and Gulf infrastructure disruption: further outages would continue to favor LNG(Cheniere Energy), VG(Venture Global), and U.S. gas-linked names.
The trajectory of oil above current levels and whether direct Middle East operational exposure at XOM(Exxon Mobil), OXY(Occidental Petroleum), and SHEL(Shell) worsens from financial nuisance to earnings event.

Industrials

Theme: Industrials saw a powerful split between companies tied to defense, power, AI infrastructure, and grid buildout versus those simply moving with macro risk sentiment. The strongest names had visible backlog, mission-critical contracts, or direct exposure to reindustrialization and data-center infrastructure, while weaker names were more hostage to rates and geopolitics.

Movers:

ACM(AECOM): The $151 billion SHIELD contract and fusion-related UK win reframed AECOM as more than an engineering consultant. It matters because AECOM now has major exposure to two long-duration public spending themes: defense infrastructure and next-gen energy.
BAH(Booz Allen Hamilton): New AI-native cyber and simulation initiatives reinforced the company’s shift toward digital defense infrastructure. It matters because Booz Allen is becoming a direct beneficiary of AI militarization and cyber modernization.
BWXT(BWX Technologies): Continued earnings estimate revisions and its push into nuclear medicine added to the rerating story. It matters because BWXT sits at the intersection of defense and healthcare-adjacent nuclear expertise.
GE(General Electric): GE Aerospace remained the clear bright spot, supported by defense engine wins and manufacturing investment. It matters because the market is increasingly valuing GE as a focused aerospace/defense compounder, not a conglomerate recovery story.
GEV(GE Vernova): Strategic clean-energy relevance remains intact, but weak margins and expensive valuation are becoming harder to ignore. It matters because investors want clean-energy infrastructure, but not at any price without execution.
CAT(Caterpillar): Record results and a huge backlog offset tariff and input cost risk. It matters because Caterpillar remains one of the best industrial expressions of infrastructure, mining, and aftermarket monetization.
FIX(Comfort Systems USA): A massive backlog and operating leverage tied to data centers and modular infrastructure reinforced one of the market’s strongest industrial growth stories. It matters because Comfort is a direct downstream beneficiary of AI and electrification capex.
EME(EMCOR): Strong revenue growth and exposure to onshoring and infrastructure buildout kept the structural story intact. It matters because EMCOR remains levered to non-residential infrastructure and mission-critical facilities demand.
PWR(Quanta Services): Backlog and growth remain strong, but the valuation now implies little room for error. It matters because Quanta is a premier grid and electrification play, but investors are now paying peak multiples for flawless execution.
APH(Amphenol): AI-driven interconnect demand continued to support the long-term thesis. It matters because AI infrastructure requires not just chips and racks, but the underlying connectivity hardware where Amphenol is deeply embedded.
ECL(Ecolab): The CoolIT acquisition was one of the day’s more surprising industrial-tech moves, pulling Ecolab into AI data-center cooling. It matters because Ecolab is trying to become a systems player in thermal management, not just water and hygiene.
ATI(ATI Inc.): Today’s move was mostly macro-driven, but it showed how cyclical industrials remain vulnerable to inflation and energy-shock sentiment. It matters because quality alone is not insulating cyclicals from geopolitical repricing.
BA(Boeing): Inclusion in the U.S. arms package helped the defense side of the story, but did little to erase deeper execution concerns. It matters because Boeing still has strategic defense relevance, but commercial credibility remains the gating factor.
AVAV(AeroVironment): Massive growth was overwhelmed by execution misses, goodwill impairment, and program setbacks. It matters because defense growth alone isn’t enough if operational discipline collapses.
KTOS(Kratos Defense): Continued to gain favor as a cleaner defense-tech execution story than some peers. It matters because investors are rewarding smaller defense names where growth and execution are both intact.
TDY(Teledyne): SATShow innovation reinforced its role in space, sensing, and edge-intelligence hardware. It matters because Teledyne remains one of the more underappreciated high-spec industrial tech franchises.

Watch:

AI/data-center power and cooling demand as a cross-industrial catalyst for FIX(Comfort Systems USA), EME(EMCOR), PWR(Quanta Services), APH(Amphenol), and ECL(Ecolab).
Defense-tech execution at AVAV(AeroVironment), KTOS(Kratos Defense), and BAH(Booz Allen Hamilton), where investors are increasingly separating backlog stories from actual delivery.

Transportation

Theme: Transportation was dominated by a two-track narrative: airlines were hit by the direct consequences of the oil shock and operational disruption, while freight, leasing, and logistics names were judged more on earnings resilience and structural positioning. The sector is now one of the clearest transmission channels from geopolitics into equities.

Movers:

DAL(Delta Air Lines): Delta’s revenue outlook and pricing power story held up better than peers, but the market remained focused on elevated jet fuel costs and the risk of margin erosion. It matters because Delta is the sector’s best test of whether premium demand can offset sustained fuel inflation.
UAL(United Airlines), AAL(American Airlines), LUV(Southwest Airlines), and ALK(Alaska Air Group): All sold off on the same core issue—oil shock plus travel disruption. It matters because the sector’s long-term demand recovery is now colliding with a direct, immediate cost squeeze.
FDX(FedEx): A strong beat-and-raise report proved operational self-help can still matter even in a difficult macro backdrop. It matters because FedEx is showing logistics names can still expand earnings through cost discipline and network optimization.
JBHT(J.B. Hunt): The intermodal and driver-constraint story remains strategically important despite a difficult freight backdrop. It matters because structural driver scarcity can ultimately improve pricing power for scaled operators.
WAB(Wabtec): Earnings consistency and a dividend hike gave investors a higher-quality transportation equipment story. It matters because Wabtec is a steadier way to play transport infrastructure than freight-sensitive names.
AER(AerCap): Continued to benefit from durable aircraft leasing fundamentals and execution. It matters because AerCap remains one of the cleaner aviation exposures when airlines themselves are under margin pressure.
CPRT(Copart): Downgrades and concerns over pricing power weakened the near-term story. It matters because even niche transport-related franchises are being forced to prove margin durability.
CCL(Carnival) and BKNG(Booking Holdings): Travel demand remains resilient, but fuel and macro sensitivity are back in focus. It matters because the market wants proof that leisure demand can absorb cost inflation without cracking.

Watch:

Airline fuel commentary and fare pass-through from DAL(Delta Air Lines), UAL(United Airlines), and peers; this is the sector’s most important near-term earnings variable.
Freight and logistics self-help at FDX(FedEx) and JBHT(J.B. Hunt) as a test of whether operators can offset a macro backdrop that remains far from clean.

Consumer Discretionary

Theme: Consumer discretionary was marked by sharp stock selection, with investors rewarding companies showing clear execution, pricing strategy, or expansion visibility, while punishing those with governance issues, weak guidance, or overextended growth narratives. The key divide was between brands still proving demand resilience and those